Holmlin R. Erik 4
4 · Bionano Genomics, Inc. · Filed Feb 18, 2026
Research Summary
AI-generated summary of this filing
Bionano (BNGO) CEO Erik Holmlin Withholds 51 Shares for Taxes
What Happened Erik R. Holmlin, President & CEO and a director of Bionano Genomics (BNGO), had 51 shares withheld by the company on Feb 17, 2026 to satisfy tax withholding obligations tied to an RSU settlement. The filing reports the shares at $1.10 each, for a notional value of about $56. This was a tax-withholding event (transaction code F), not an open-market sale or purchase.
Key Details
- Transaction date: 2026-02-17; reported on Form 4 filed 2026-02-18 (timely).
- Price: $1.10 per share; 51 shares withheld; total ≈ $56.
- Shares were withheld to cover tax on RSUs that vested on 2026-02-15 from an award granted 2023-02-15 (per footnote).
- The withheld shares were not issued to the reporting person (they were retained by the issuer to satisfy tax obligations).
- Shares owned after the transaction: not specified in the provided filing details.
- Transaction code: F (tax withholding).
Context This is a routine tax-withholding action tied to RSU vesting and does not represent a market sale or a deliberate purchase decision by the insider. Such withholdings are common when restricted stock units vest and generally do not signal management’s view of the company’s prospects.
Insider Transaction Report
- Tax Payment
Common Stock
[F1]2026-02-17$1.10/sh−51$56→ 1,657 total
Footnotes (1)
- [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.